Clinical Trials

Multiple Phase I clinical trials were designed to address distinct questions on the safety and clinical activity of Neukoplast in different cancer patient populations.

40 patients have already received Neukoplast, with two of the phase I studies already completed with two ongoing, all demonstrating Neukoplast is exceptionally well tolerated and safe.

Encouraging clinical activity was also observed in these seriously ill, heavily pretreated patients leading experts to favorably anticipate mid-stage clinical trials.

A multi-center, non-randomized, non-blinded, open-label, Phase II trial for patients with Merkel Cell Carcinoma is anticipated to begin shortly.

Clinical Studies